PAR 4.65% 22.5¢ paradigm biopharmaceuticals limited..

Its been done before., page-2

  1. 5,283 Posts.
    lightbulb Created with Sketch. 145
    Results
    Hydrarthroses were reduced quickly in all cases. The clinical assessments, i.e., knee flexion, pain while walking, pain after climbing up and down stairs, etc, were improved significantly and these clinical improvements continued for almost one year. The dose used in thisstudy affected the blood coagulation test,but was within safe levels. Slightly abnormal findings were noted in serum triglycerides.

    Coagulation tests measure your blood’s ability to clot, and how long it takes to clot.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
0.010(4.65%)
Mkt cap ! $78.73M
Open High Low Value Volume
22.0¢ 23.5¢ 21.5¢ $288.5K 1.279M

Buyers (Bids)

No. Vol. Price($)
6 130626 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 60000 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.